USP9X and glioblastoma: Consistent with the subcutaneous model, knockdown of HDAC6 and USP9X notably suppressed GBM tumor growth (Figure 6G–I; Figure S7, Supporting Information) and reduced Ki‐67 and GS expression (Figure 6J–L) in the intracranial model.